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Purpose: To develop a dry  eye  model  of  mouse  induced  by topical  administration of  benzalkonium chloride (BAC) and
investigate the possible mechanisms.
Methods: BAC at concentration of 0.2% was applied to the mouse ocular surface for 7 days. Phenol red thread tear test,
tear break-up time (BUT) test,  corneal  inflammatory  index  scoring,  fluorescein  and rose  bengal test were performed to
evaluate the toxic effects of BAC on the ocular surface. Global specimens were collected on day (D) 7 and labeled with
a  series  of  antibodies  including  cytokeratin 10  (K10)  and  mucin 5AC  (MUC5AC).   Apoptosis  of  ocular  surface
epithelium  was  evaluated  by  in  situ   terminal  deoxynucleotidyl  transferase  dUTP   nick  end   labeling  (TUNEL)  assay.
Histologic analysis and transmission electron microscopy (TEM) were performed on D7.
Results: BAC at a concentration of 0.2% successfully induced a dry eye condition with decreased tear volume and BUTs,
increased corneal fluorescein and rose bengal scores. The Inflammatory index was increased in accompanyment with
higher tumor necrosis factor-α (TNF-α) expression and more inflammatory infiltration in the cornea. Immunolabeling
revealed positive K10 expression in BAC-treated corneal epithelium and fewer MUC5AC-positive cells in the BAC-
treated conjunctival fornix. TUNEL assay showed more apoptotic cells in the corneal basal epithelium. TEM showed that
the size and intervals of the microvillis were both reduced in the corneal epithelium.
Conclusions: Topical administration of 0.2% BAC in mouse induces changes resembling that of dry eye syndrome in
humans, and thus, represents a novel model of dry eye.
Dry eye syndrome, or keratoconjunctivitis sicca (KCS),
is one of the most common ocular diseases [1,2], affecting tens
of million of population worldwide. With the symptoms of
ocular dryness and discomfort, dry eye syndrome can lead to
visual  disturbance  and  tear  film  instability  with  potential
damage to ocular surface, impacting the ability to work, read
and drive at night. There is emerging evidence showing that
the  immunopathogenesis  of  dry  eye  is  complicated  and
multifactoral, involving chronic inflammatory infiltration of
lacrimal and salivary glands, as well as other ocular surface
tissues, interruption of neuronal stimulation for tear secretion,
defects of transmembrane and secretory mucin expression, as
well  as  meibomian  gland  dysfunction,  topical  drugs
preservatives, etc. Unfortunately, the precise mechanisms of
dry eye syndrome were not fully understood [3].
Numerous animal models [4] have been developed to
reflect  the  multiplicity  of  pathophysiological  mechanisms
involved in dry eye. Although the data gathered from these
previous studies have provided better insights into dry eye,
different  models  have  their  unique  characteristics  and
limitations. Benzalkonium chloride  (BAC) is one of the most
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commonly used preservative in ophthalmic solutions. The
topical  drugs  containing  preservatives  have  long  been
recognized as a potential risk of dry eye syndrome [5,6].
Recently, Xiong et al. [7] successfully developed a BAC-
induced  rabbit  dry  eye  model  with  twice-daily  topical
medication, based upon the observation of reduced aqueous
volume, increased fluorescein and rose bengal staining scores,
and decreased goblet cell numbers.
However, our further understanding of this rabbit model
was limited due to the poor availability of antibodies against
rabbit proteins. In addition, it was speculated that several
important pathological alterations were involved in this BAC-
induced dry eye, such as inflammatory infiltration, apoptosis,
and squamous metaplasia in the epithelium. The present study
was therefore conducted to evaluate the effect of BAC on the
ocular surface of normal mice, aiming to develop a mouse dry
eye model with topical administration of BAC, and more
importantly,  to  provide  a  better  recognition  of  the
preservative-induced  dry  eye  models  and  their  use  in
mechanistic and therapeutic study design.
METHODS
Animals  and  procedures  of  benzalkonium  chloride
administration:  Twenty  male  BALB/c  mice  (18–20  g,
purchased from Shanghai SLAC laboratory animal center,
Shanghai, China) were used for this study. The mice were kept
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257in  standard  environment  throughout  the  study  as  follows:
room temperature 25 °C±1 °C, relative humidity 60%±10%,
and alternating 12 h light-dark cycles (8 AM to 8 PM). All
procedures were performed in accordance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research.
The right eyes of randomly chosen 10 mice was treated
with twice-daily (9 AM, 9 PM) topical administration of 5 μl
of 0.2% BAC as the BAC-treated group, while the other 10
mice were treated with PBS in the right eyes as the PBS-
control group. The ophthalmic preparation was adjusted to
iso-osmia before used. The frequency and concentration of
BAC  medication  were  selected  based  on  the  data  of  our
preliminary pilot experiments.
Experimental procedure: Schirmer test, inflammatory index,
fluorescein staining, break-up time of tear film (BUT), and
rose  bengal  staining  were  performed  in  order  before  and
during the treatment in both groups (on days 0, 1, 4, and 7).
On day 7, all mice were sacrificed and the ocular global tissues
were  carefully  dissected  and  harvested  for  histological
analysis and western blot following the methods described
below.
Measurement  of  tear  volume:  The  amount  of  tears  was
measured with the phenol red thread tear test using ZONE-
QUICK cotton threads (Yokota, Tokyo, Japan) [8,9] on days
0, 1, 4, 7, at similar time point of the day (3 PM) in the standard
environment. Animals were kept immobile by intraperitoneal
injection of 1 mg pentobarbital. The lower eyelid was pulled
down slightly, and a 1 mm portion of the thread was placed
on  the  palpebral  conjunctiva  at  a  specified  point
approximately 1/3 of the distance from the lateral canthus of
the lower eyelid. Each eye in two groups was individually
tested with the eyes open for 15 s. The red portion of the thread
is measured in millimeters. Each eye was tested 3×, and the
average length of red portion was considered as the final
length.  After  the  test,  eyes  were  turned  closed  to  avoid
excessive exposure and irritation of ocular surface.
BUT, fluorescein and rose bengal staining: One microliter of
0.1%  liquid  sodium  fluorescein  was  dropped  into  the
conjunctival  sac.  After  3  blinks,  BUTs  were  recorded  in
seconds. Ninety seconds later, corneal epithelial damage was
graded with a cobalt blue filter under a slit-lamp microscope
(Kanghua  Science  &  Technology  Co.,  Ltd,  Chongqing,
China). The cornea was divided into 4 quadrants, which were
scored, respectively. The 4 scores were added to arrive at a
final  grade  (total,  16  points).  The  fluorescein  score  was
analyzed  as  previously  described  [10]  with  essential
modification, briefly, as follows; absent, 0; slightly punctate
staining less than 30 spots, 1; punctate staining more than 30
spots, but not diffuse, 2; severe diffuse staining but no positive
plaque, 3; positve fluorescein plaque, 4.
One microliter of 1% rose bengal was instilled into the
conjunctival sac. Fifteen seconds later, the scores were graded
under slit-lamp microscope using the Van Bijsterveld system
[11].  Representative  images  of  each  scale  in  the  grading
system were provided (Figure 1E-L).
Evaluation  of  inflammation:  Inflammatory  response  was
evaluated by slit lamp on days 0, 1, 4, 7. The inflammatory
index was analyzed as previously described [12]. Briefly, the
inflammatory index was evaluated, based on the following
parameters: ciliary hyperemia (absent, 0; present but less than
1 mm, 1; present between 1 and 2 mm, 2; present more than
2 mm, 3); central corneal edema (absent, 0; present with
visible iris details, 1; present without visible iris details, 2;
present without visible pupil, 3); and peripheral corneal edema
(absent, 0; present with visible iris details, 1; present without
visible iris details, 2; present with no visible iris, 3). The final
inflammatory  index  result  was  obtained  by  summing  the
scores of the different parameters divided by a factor of 9.
In situ terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) labeling: To measure end-stage apoptosis,
in situ TUNEL labeling was performed in frozen sections of
the two groups using the DeadEnd™ Fluorometric TUNEL
System  (G3250;  Promega,  Madison,  WI)  according  to
manufacturer's  instructions.  Cryosections  were  fixed  in
acetone at 4 °C, rinsed with phosphate-buffer saline(PBS),
permeabilized by 0.2% Triton X100, followed by incubation
in  equilibration  buffer  for  10  min.  Sections  were  further
incubated with TdT reaction mix for 60 min, then immersed
in  standard  saline  citrate  to  stop  reaction.  After  a  rinse,
sections  were  counterstained  with  4',6-diamidino-2-
phenylindole (DAPI; Vector, Burlingame, CA), mounted, and
the photo images were taken with a confocal laser scanning
microscope (Fluoview FV1000; Olympus, Tokyo, Japan). For
a positive control, sections were incubated in DNase I before
addition of equilibration buffer, while DDW was used instead
of TdT reaction mix in the negative control.
Immunofluorescent  staining:  Immunofluorescent  staining
was performed on cryosections (6 μm thick) of the eyeballs.
Sections  were  fixed  in  acetone  at  −20  °C,  blocked,  and
incubated at 4 °C overnight with an anti-MUC5AC or an anti-
K10 antibody (all 1:50; Santa Cruz Biotechnology, CA). After
incubation  in  AlexaFluor488-conjugated  IgG  (1:1,000;
Invitrogen, Carlsbad, CA), sections were counterstained with
propidium  iodide  (Vector)  or  DAPI,  mounted,  and
photographed using a confocal laser scanning microscope
(Fluoview  1000;  Olympus).  Cornea  and  conjunctiva  were
scanned in the same area in both groups. For MUC5AC, 6
sections of each eye were used to calculate the average goblet
cell number with positive cytoplasmic MUC5AC.
Western blotting: Proteins of the cornea and conjunctiva from
each  group  were  extracted  with  cold  RIPA  buffer.  Equal
amounts  of  proteins  of  the  cell  lysates  were  subjected  to
electrophoresis  on  8%  SDS–PAGE  and  then
electrophorectially transferred to PVDF membranes. After 1
h blocking in 5% BSA, the membranes were incubated with
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MA)  and  β-actin  (1:10,000;  Sigma,  St.  Louis,  MO)  as  a
loading control. After three washes with Tris-buffered saline
with 0.05% Tween-20 for 10 min each, the membranes were
incubated  with  HRP-conjugated  goat  anti-rabbit  IgG
(1:10,000; Bio-Rad, Hercules, CA) for 1 h. The specific bands
were  visualized  by  enhanced  chemiluminescence  reagents
and recorded on film.
Transmission  electron  and  light  microscopy:  On  day  7
following BAC treatment, two eyes randomly selected from
each group were enucleated and fixed for 2 h in the mixture
of 2.5% glutaraldehyde and 4% paraformaldehyde in PBS
(pH=7.4).  Then,  the  specimens  were  separated  without
touching the epithelium, with 2×4-mm size for both the cornea
and conjunctiva. After further dissection, embedding, slicing
and staining, specimens were examined and photographed
with  TEM  (JEM2100HC;  JEOL,  Tokyo,  Japan).  Light
microscopy was performed in cryosections of both groups.
Tissues were stained with hematoxylin and eosin (H&E).
Statistical analysis: Statistical analysis was performed with
SPSS 16.0.0 (SPSS, Chicago, IL). One-way ANOVA was
applied in all comparisons between groups. P-values less than
0.05 were considered statistically significant.
RESULTS
Effects of BAC at different concentrations: The effects of BAC
at different concentrations (0.1%, 0.2%, 0.25%, and 0.5%)
and frequencies (2–4 times/day, daily) within 1 week were
evaluated  with  inflammation  scoring,  Schirmer  test,  and
ocular surface staining as mentioned above. Based on the
preliminary results, topical instillation of BAC at 0.2% twice-
daily for 7 days was considered as the optimal procedure to
induce  dry  eye  syndrome  in  BALB/c  mice.  Higher
concentration  of  BAC  caused  severe  damage  to  ocular
surface,  such  as  ulceration,  large  epithelial  defects  and
neovascularization within 7 days, while BAC at 0.1% did not
exhibit obvious effect regardless of the frequency and the
duration (data not shown).
Aqueous  tear  volume:  At  baseline  (day  0),  no  significant
differences  were  found  between  PBS-treated  and  BAC-
treated groups. The tear volume declined rapidly in the BAC-
treated group after the treatment, compared with the PBS-
treated group. There were statistically significant differences
on day 4 and 7 between the two groups (p<0.001, Figure 1A).
No statistical differences were recorded at baseline.
Stability of tear film and epithelium damage: At baseline, no
differences of BUTs or scores of epithelium damage were
found between the two groups. In the BAC-treated group,
BUTs were significantly shortened compared with the PBS-
treated  group  (p<0.001,  Figure  1B),  while  scores  of
fluorescein  sodium  (Figure  1C)  and  rose  bengal  staining
(Figure 1D) significantly increased after treatment (p<0.001).
Within  PBS-treated  group,  BUTs  were  slightly  shorten
Figure 1. The alterations of the ocular surface after BAC treatment. Phenol red thread test showed decreased tear volume production (A), and
decreased BUTs were described (B). Increased corneal fluorescein staining and rose bengal scores of ocular surface were recorded (C and
D, respectively). *p<0.05, **p<0.01, ***p<0.001, respectively. Representative examples for each scale of fluorescein sodium staining (E-
H, 0, 1, 2, 3 points respectively), and rose bengal staining (I-L, 0, 1, 2, 3 points respectively).
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259without  significant  differences  (p>0.05).  However,
epithelium damages also appeared from baseline in the PBS-
treated group, probably due to the repeated manipulations and
the toxicity of the dyes.
Inflammation:  The  corneas  treated  with  BAC  showed
significant increase in inflammatory index at all of the time
points (p<0.001, Figure 2A). Histological analysis of serial
sections  revealed  that  the  BAC-treated  group  had  more
inflammatory cell infiltration in the peripheral cornea (Figure
2D) than the PBS-treated group (Figure 2C). In the central
cornea,  more  epithelial  damages  and  inflammatory
infiltrations were observed in the BAC-treated eyes (Figure
2F)  compared  with  that  of  the  control  (Figure  2E).  The
expression of TNF-α was upregulated in both the cornea and
conjunctiva after BAC treatment (Figure 2B).
Apoptosis and squamous metaplasia: TUNEL assay of frozen
sections revealed that BAC dramatically induced apoptosis in
the corneal basal epithelium, but not in the stroma, while the
PBS-treated  cornea  showed  few  apoptotic  cells  in  the
superficial corneal epithelium (Figure 3A,B), suggesting that
BAC  probably  induced  apoptosis  specifically  in  corneal
transient  amplifying  cells  (TACs)  but  not  terminated
differentiated  cells.  K10  was  positively  expressed in the
corneal  epithelium  after   the  BAC  treatment   for  7  days
(Figure 3C,D), indicating the epithelial suqamous metaplasia.
Density  of  goblet  cells:  Immunofluorescent  staining  of
MUC5AC revealed an obvious downregulation of MUC5AC-
positive cells in the conjunctival fornix of the BAC group on
day 7 (Figure 4D, p<0.01).
Ultra-structural changes: Consistent with the previous study
from  another  group  [7],  the  microvilli  of  the  corneal
epithelium were partially destroyed after BAC treatment. The
size and intervals of microvilli were both reduced (Figure 5).
DISCUSSION
Dry eye has long been considered as a complicated condition
which is multifactoral and can be related to any deficiencies
Figure  2.  Analysis  of  degrees  of
inflammation after BAC treatment. A:
Increased  corneal  inflammatory  index
after BAC treatment. TNF-α expression
was  elevated  in  both  the  cornea  and
conjunctiva (B). Representative images
showed more inflammatory infiltration
in peripheral corneal stroma after BAC-
treatment (D) compared with that of the
control  (C).  In  central  cornea,  fewer
layers of epithelium and more epithelial
damage in BAC-treated eyes (F) were
observed than that of the control (E).
Scale bar=100 μm.
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260in any of the components of the ocular surface and tear film.
Developing  a  good  animal  model  that  simulates  dry  eye
problems  would  be  important  for  the  elucidation  of
pathogenesis  and  the  evaluation  of  promising  therapeutic
treatments of dry eye diseases. In this study, we introduced a
mouse  mode  of  dry  eye  induced  by  short-term  topical
application of a commonly used preservative, BAC, in the eye
drops.  The  clinical  assessments  demonstrated  that  the
manifestations  of  ocular  disorders  induced  by  topical
administration of 0.2% BAC were consistent with human dry
eye. Our findings revealed that BAC-induced dry eye model
developed  several  pathological  changes  accordant  with
human dry eye syndrome, notably including inflammation,
epithelial apoptosis and squamous metaplasia, which are all
considered essential in the pathogenesis of dry eye syndrome.
Quaternary ammonium preservatives possess detergent
properties that modify the lipid phase of the tear film and
damage the integrity of epithelial cell membrane, leading to
the rapid and progressive decline of tear stability. As the most
commonly used preservative in ophthalmic solutions, BAC is
widely known to be detrimental to ocular surface [6,10,13]
and a BAC-induced rabbit model of dry eye has been recently
reported  [7].  Our  findings  further  support  existing  data
showing that BAC is able to induce a murine dry eye condition
clinically similar to that in human. Squamous metaplasia,
inflammatory infiltration, abnormal expression of immune
mediators, and increased epithelial apoptotic rates were all
observed  in  this  BAC-induced  dry  eye  model,  and  these
results were consistent with those in the ocular surfaces in
patients receiving prolonged topical treatment [14].
Inflammation is the key mechanism of ocular surface
injury  and  dryness,  as  both  the  cause  and  consequence.
Epithelial squamous metaplasia and apoptosis could be the
consequences of inflammation [10,15,16]. Chronic dryness of
the ocular surface resulted in gradual dysfunction of lacrimal
glands and vice versa [17]. Goblet cell number could also be
reduced under chronic or severe inflammation [18,19]. In our
mouse model, tear secretion significantly reduced at the late
phase of BAC treatment (D4 and D7). In fact, the aqueous
component  of  tear  film  mainly  came  from  the  accessory
lacrimal glands and conjunctiva. The tear volume reduction
was probably secondary to damages and severe dryness of
ocular  surface,  since  no  difference  of  inflammatory
infiltration  between  two  groups  was  observed  in  tissue
sections of the main lacrimal glands (data not shown).
Squamous metaplasia is a hallmark of a variety of severe
ocular surface disorders including chronic dry eye [20], and
always  happens  under  such  as  long-term  deficiency  of
lacrimal secretion and chronic inflammatory infiltration of the
ocular surface [21,22]. Our data revealed the emergence of
epidermis-specific K10 expression, indicating that the non-
keratinized epithelium was replaced by squamous epithelium.
Li  et  al.  [22]  revealed  that  dryness-induced  squamous
metaplasia, including both abnormal epithelial differentiation
and proliferation, could be observed in air-exposed limbal
epithelium tissues. However, only abnormal differentiation
was recorded in our mouse model, as no p63 expression was
detected in the basal epithelium in the cornea of BAC-treated
groups (data not shown).
Figure  3.  Representative  images  for
TUNEL  assay  and  cytokeratin  10
immunolabeling. Only a few apoptotic
cells were observed in the superficial
layer of corneal epithelium in control
group (A), while much more apoptosis
were  recorded  in  corneal  basal
epithelium  after  BAC  treatment  (B).
K10 was positive in corneal epithelium
after BAC treatment (D) and negative in
the control (C).
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261The role of pathological apoptosis in the pathogenesis of
dry eye has been established based on a series of studies
[23-25]. Apoptotic cell death was detected on ocular tissues
including cornea and especially conjunctiva, as well as the
lacrimal gland. In cell cultures, preservatives could induce
apoptosis  at  low  concentrations  and  necrosis  at  high
concentrations [26]. The similar phenomenon was also found
in animal models and patients with dry eye [10,27]. Protection
against  ocular  surface  disorders  could  be  achieved  by
suppression of apoptosis [25,28]. Our data showed notably
more  apoptosis  in  corneal  basal  epithelium  rather  than
superficial epithelium after BAC treatment, while only a few
apoptotic  cells  were  found  in  the  extremely  superficial
epithelium  in  the  control.  The  alteration  of  TACs  might
contribute to interruption of epithelium renewal, thus leading
to  severe  corneal  epithelium  damage  representing  high
fluorescein  and  rose  bengal  staining  scores.  The  basal
epithelium presented more apoptotic cells than the superficial
epithelium under BAC treatment; however, the underlying
mechanisms were unclear. It was speculated that as a small
molecular,  BAC  might  easily  penetrate  to  the  basal  layer
containing TACs, which might be more sensitive to BAC.
However,  further  study  is  needed  to  clarify  the  precise
mechanisms.  We  did  not  obtain  the  similar  results  in  the
conjunctiva, probably due to the minor ratio of conjunctival
area directly exposed to BAC drops in mouse ocular surface.
Figure  4.  Representative  images  for
MUC5AC staining in the conjunctiva.
In  the  conjunctival  fornix,  more
MUC5AC positive cells in the control
group (A) were observed than that of the
BAC-treated group (B), while none was
recorded in the bulbar conjunctiva near
limbus  (C).  The  average  number  of
MUC5AC  positive  cells  was
significantly  decreased  after  BAC
treatment (D). **p<0.01.
Figure  5.  Representative  images  of
transmission  electron  microscopy.
Shown are the flatten microvillis with
larger  intervals  between  them  on  the
cellular surface of epithelium after BAC
treatment  (B,  black  arrows).  The
microvillis were sharp with highdense
in the control group (A, black arrows).
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262Various animal models [4,29-32] have been developed to
imitate  different  pathophysiologic  mechanisms  in  the
development of dry eye in the past decade. However, none of
them  precisely  mimic  the  clinical  manifestations  and  the
pathogenesis of human dry eye. Based on the property of
preservatives, our BAC-induced dry eye models could be
categorized  as  evaporative  subtype  and  has  its  unique
characteristics and limitations. Due to good availability of
antibodies and transgenic variety, the mouse models are most
commonly  used  for  the  clarification  of  immunologic
mechanisms  involving  lacrimal  gland  and  ocular  surface
inflammation.  This  mouse  model  can  be  appropriate
especially  for  the  study  of  inflammatory  dry  eye.  As  the
inflammation plays an important role, the therapeutic effects
of anti-inflammatory agents could be evaluated in the therapy
of dry eye using this BAC-induced mouse model.
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